Episode 713
TWiV 713: COVID-19 clinical update #47 with Dr. Daniel Griffin
January 30, 202134m 57s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In COVID-19 clinical update #47, Daniel Griffin reviews phase 3 results for Novavax and J&J vaccines, transmission in K-12 settings in Wisconsin, data on Lilly and Regeneron monoclonal antibody therapy, and a study of colchicine for treatment of disease.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Novavax vaccine phase 3 results (Novavax)
- J&J vaccine phase 3 results (J&J)
- COVID-19 and transmission in K-12 schools (MMWR)
- Lilly mAb therapy (NEJM)
- Regeneron mAb prophylaxis (Regeneron)
- Colchicine for COVID-19 (Cardiol Today)
- Letters read on TWiV 713
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]